2.1.1 Amide Linkage Drug Conjugation
2.1.2 Drug Conjugation with pH-Sensitive Bonding
2.1.3 Drug Conjugation with Enzymatically Responsive Bonding
2.1.4 Oxidation/Reduction Drug Conjugation

2.2.1 Hydrophobic Drug Conjugation
2.2.2 Drug Conjugation Using Electrostatics
2.2.3 Drug Conjugation with Encapsulation

3.1.1 Deposition in the Gas Phase
3.1.2 Lithography Using Electronic Beam
3.1.3 Laser Ablation with Pulses
3.1.4 Pyrolysis Caused by a Laser
3.1.5 Strong Ball Milling
3.1.6 Combustion

3.2.1 Chemical Coprecipitation Synthesis
3.2.2 Thermolysis (Thermal Decomposition)
3.2.3 Microemulsions
3.2.4 Synthesis Using Hydrothermal Method

4.1.1 Colloidal Stability
4.1.2 Shape and Size
4.1.3 Charge of Surface

4.4.1 Fluorescence Techniques and Encapsulated IONPs

5.1.1 Size and Coating Material’s Impact on Absorption
5.1.2 Charge’s Impact on Uptake and Absorption
5.1.3 Uptake of IONPs in the Brain

5.2.1 Iron and IONP Physicochemical Properties Affecting the Distribution

5.4.1 Influence on Cell Proliferation
5.4.2 Effect on Stem Cell Differentiation
5.4.3 Affects Cell Migration

5.6.1 Human Body’s Iron Flow
5.6.2 The Liver Is the Main Organ for Iron Homeostasis
5.6.3 Iron Regulation
5.6.4 Macrophages Are in Charge of Iron Homeostasis
5.6.5 Monocytes and the Iron Metabolism Process
5.6.6 Iron-Related Infection and Immunity

6.1.1 Organic Ligands
6.1.2 Inorganic Ligands
6.1.3 Hybrid Inorganic-Organic Ligands

6.2.1 Thin Films Hydration
6.2.2 Evaporation Emulsion
6.2.3 Solvent Exchange

7.2.1 Endogenous Stimuli-Responsive Nanoplatforms
7.2.2 Nanoplatforms That Deliver in Response to Exogenous Stimuli
7.2.3 Delivery Platform with Dual-Stimuli

7.3.1 Passive Targeting
7.3.2 Active Targeting

7.5.1 Current Restrictions on the Use of Photodynamic Therapy in Cancer

7.7.1 Magnetic Hyperthermia Principles and Clinical Application
7.7.2 Magnetic Hyperthermia and MRI
7.7.3 Effect of Particle Structure, Composition, and Aggregation on Magnetic Properties
7.7.4 Multicomponent IONPs for Heating and Imaging

7.9.1 Radiotherapy and Real-Time Monitoring of Oxygen Delivery Nano-platforms

8.1.1 Important Factors Improving the T2 Relaxivities of IONPs
8.1.2 T1 CA with IONP
8.1.3 Dual-Modal IONP-Based Imaging
8.1.4 Responsive MRI CAs Based on IONP
8.1.5 IONP Behavior Optimization in Vivo
8.1.6 Greater Biocompatibility

8.4.1 PET or Positron Emission Tomography
8.4.2 SPECT, or Single-Photon Emission Computed Tomography

9.1.1 Devices for Colorimetric Biosensing
9.1.2 Devices for Fluorescent Biosensing
9.1.3 Devices for Surface Plasmon Resonance Biosensing
9.1.4 Devices for Surface-Enhanced Raman Scattering Biosensing

9.2.1 Devices for Potentiometric Biosensing
9.2.2 Devices for Conductometric Biosensing
9.2.3 Devices for Amperometric Biosensing
9.2.4 Devices for Impedimetric Biosensing

11.4.1 Mechanisms
11.4.2 Animal Studies
11.4.3 Genotoxicity